dementia glp-1 Receptor Agonists Linked to Lower Risk, Observational Studies Find Dementia and Alzheimer's Disease Risk

They may require prior authorizations or step therapy, which means proving to the insurance company that youve tried and failed other medications first

The results of the phase 3 clinical trial of retatrutide are eagerly awaited, as it is expected that over a longer time period its efficacy in weight loss will be even greater

The pleiotropic effects of GLP-1 RAs, encompassing metabolic, vascular and anti-inflammatory benefits, address multiple facets of HF pathophysiology

Uncommon Risks & Side Effects While serious side effects are rare, GLP-1s may increase the risk of: Gallstones Pancreatitis Low Blood Sugar If you experience any of these symptoms or persistent side effects, its important to inform your physician right away

The research isnt definitive, but some studies have shown promise